Search Results - "Suvorova, M P"

Biapenem: Clinical and Microbiological Characteristics and the Place of The New Carbapenem In The Treatment of Severe Infections In The Hospital. Clinical Pharmacologists' Point of View by S. V. YAKOVLEV, M. P. SUVOROVA

“…A new carbapenem antibiotic — biapenem — previously used only in Japan and Southeast Asia, was registered in Russia in 2021. The article analyzes the…”
Get full text

Infections Caused by Carbapenem-Resistant Enterobacterales: Epidemiology, Clinical Significance, and Possibilities for Antibiotic Therapy Optimization by S. V. Yakovlev, M. P. Suvorova, A. O. Bykov

“…The resistance of Enterobacterales to carbapenems can be realized by different mechanisms, but the most common one is enzymatic, associated with the production…”
Get full text

Clinical efficacy of the antimicrobial drug furamag in nosocomial urinary tract infections by Iakovlev, S V, Suvorova, M P, Kolendo, S E, Burmistrova, E N, Sergeeva, E V, Cherkasova, N A, Eremina, L V

“…To evaluate the efficacy of the combined drug furamag (furasidine potassium and magnesium hydroxycarbonate) in combination with the third-generation…”
Get full text

Cefepime/Sulbactam — A New Innovative Antibiotic for In-Hospital Treatment of Severe Infections and the Implementation of Carbapenem-Replacement Strategy to Contain Antibiotic Resistance by S. V. Yakovlev, M. P. Suvorova, A. O. Bykov

“…Cefepime/sulbactam is a combined antibiotic consisting of the 4 th generation cephalosporin cefepime and the beta-lactamase inhibitor sulbactam in 1:1 ratio…”
Get full text

A pilot study of the clinical significance and outcomes of infections in the ICU caused by colistin-resistant Klebsiella pneumoniae by Sychev, I. N., Ignatenko, O. V., Yakovlev, S. V., Fedina, L. V., Burmistrova, E. N., Suvorova, M. P., Rastvorova, T. D., Strigunkova, E. V., Mukhamadiev, R. Kh

“…The objective was to study the risk factors, outcomes of infections caused by colistin-resistant K. pneumonia (CRKP) and to evaluate the  sensitivity of these…”
Get full text

The First Experience of Combined Use of Cefepime/Sulbactam and Aztreonam in ICU Patients with Nosocomial Infections Caused by Carbapenem-Resistant Gram-Negative Microorganisms Producing Class B and D Carbapenemases by M. P. Suvorova, I. N. Sychev, O. V. Ignatenko, E. N. Burmistrova, S. S. Mirzakhamidova, L. V. Fedina, R. M. Vakolyuk, S. V. Yakovlev

“…Background. The difficulties of antibacterial therapy of infections caused by carbapenemase-producing  gram-negative bacteria are associated with limited options…”
Get full text

Septic Pulmonary Embolism in a Patient with Generalized Salmonellosis: a Clinical Case and Meta-Analysis by A. D. Strutynskaya, M. A. Karnaushkina, I. E. Tyurin, M. P. Suvorova, S. V. Yakovlev

“…Nontyphoid Salmonella are gram-negative bacteria that induce Th1-mediated immunity. They rarely lead to a generalized infection, primarily developing in…”
Get full text

An Open-Label, Multicenter, Observational Study of The Effectiveness of The Cefepime/Sulbactam Antibiotic (Maxictam®-AF) In Patients With Intra Abdominal Infection, Nosocomial Pneumonia or Ventilator-Associated Pneumonia (Study MAXI-2019) by S. V. Yakovlev, M. P. Suvorova, A. O. Bykov, S. V. Zhuravel, K. A. Popugaev, L. Yu. Kulagina, I. N. Ochakovskaya, M. G. Fedorova, O. V. Pribytkova, A. A. Zateyshchikova, O. G. Malkova, T. N. Malorodova, E. S. Nekaeva, N. G. Ogonkin, Yu. A. Strezh, I. N. Sychev, O. I. Tazieva, S. G. Fominykh

“…The aim of the study was to evaluate the effectiveness of cefepime/sulbactam in patients with intra-abdominal infection, nosocomial pneumonia (NP) or…”
Get full text

Nosocomial urinary tract infections by Yakovlev, S V, Suvorova, M P

Get more information

Cefotaxime/Sulbactam: an Important Addition to the Arsenal of Inhibitor-Protected Beta-Lactam Antibiotics by S. V. Yakovlev, M. P. Suvorova

“…A new inhibitor-protected beta-lactam antibiotic has been registered in Russia, a fixed combination of antistreptococcal cephalosporin III, cefotaxime and…”
Get full text

Rationale for choosing an antibiotic for the treatment of cystitis: recommendations of clinical pharmacologists: A review by Yakovlev, Sergey V., Suvorova, Margarita P.

“…In recent years, the harmonization of domestic and foreign clinical recommendations for the treatment of cystitis has been achieved. Nitrofurans and fosfomycin…”
Get full text

Iatrogenic Events During Antibiotic Therapy (Pulmonary Disease) by L. I. Dvoretsky, M. P. Suvorova, S. V. Yakovlev

“…Antibiotics occupy a leading position among drugs that cause adverse drug reaction (ADR), in Russia as well. Drug-induced pulmonary disease (DIPD), which is…”
Get full text

Evaluation of efficacy and safety of josamycin (Vilprafen) in the treatment of patients with community-acquired pneumonia by Iakovlev, S V, Aleksandrova, M A, Suvorova, M P, Kostina, S A

“…Clinical and bacteriological efficacy ofjosamycin (Vilprafen), a macrolide antibiotic, was studied in 30 out- and inpatients at the age of 18 to 68 years (the…”
Get more information

Analysis of the structure of bacteremia and sensitivity to antibiotics of microorganisms isolated in intensive care units in an emergency hospital in the period from 2003 to 2021: a retrospective observational study by Bykov, А. О., Suvorova, M. P., Protsenko, D. N., Yakovlev, Sergey V., Ignatenko, O. V., Burmistrova, E. N., Sychev, I. N., Krotenko, N. P.

“…INTRODUCTION: Creation of protocols for effective empiric antimicrobial therapy is impossible without the analysis of current antibiotic susceptibility data…”
Get full text

Infective Endocarditis of Staphylococcal Etiology: Clinical Process and Antibacterial Therapy by S. V. Yakovlev, D. V. Shcheka, M. P. Suvorova, E. V. Sergeeva, N. A. Cherkasova

“…Characteristics of the clinical process of staphylococcal endocarditis in 115 inpatients and the adequacy of various regimens for their antibiotic therapy…”
Get full text

Antibiotic resistance in hospital: do we control the situation? by Iakovlev, S V, Protsenko, D N, Shakhova, T V, Suvorova, M P, Ramishvili, V Sh, Ignatenko, O V, Iaroshetskiĭ, A I, Romanovskiĭ, Iu Ia, Eremina, L V

Get more information

Анализ структуры бактериемий и чувствительности к антибиотикам микроорганизмов, выделенных в отделениях реанимации и интенсивной терапии в скоропомощном стационаре в период с 2003 по 2021 г.: ретроспективное наблюдательное исследование by А. О. Bykov, M. P. Suvorova, D. N. Protsenko, Sergey V. Yakovlev, O. V. Ignatenko, E. N. Burmistrova, I. N. Sychev, N. P. Krotenko

“…АКТУАЛЬНОСТЬ: Создание протоколов эффективной эмпирической антимикробной терапии невозможно без анализа актуальных данных чувствительности к антибиотикам. ЦЕЛЬ…”
Get full text

Multicentre Study of the Prevalence and Clinical Value of Hospital-Acquired Infections in Emergency Hospitals of Russia: ERGINI Study by S. V. Yakovlev, M. P. Suvorova, V. B. Beloborodov, E. E. Basin, E. V. Eliseev, S. V. Kovelenov, U. S. Porthyagina, A. A. Rog, V. A. Rudnov, O. N. Barkanova

Get full text

Antibiotic Resistance in Hospital: Do we Control the Situation? by S. V. Yakovlev, D. N. Protsenko, T. V. Shakhova, M. P. Suvorova, V. SH. Ramishvili, O. V. Ignatenko, A. I. Yaroshetsky, YU. YA. Romanovsky, L. V. Eremina

Get full text

Current project of management guidelines of the patients with nosocomial pneumonia in adults by Karnaushkina, Maria A., Maliavin, Andrey G., Dvoretckiy, Leonid I., Yakovlev, Sergey V., Babak, Sergey L., Fedosenko, Sergey V., Suvorova, Margarita P., Razgulyeva, Natalia F., Arutyunova, Albina B.

“…The nosocomial pneumonia is one of the most (or just “is a”) common hospital infections complicating the disease course and resulting in a fatal outcome. In…”
Get full text